Persistent Renal Oxidative Stress Despite Mannitol Nephroprotection: The Impact of Social-Single Prolonged Stress in Male and Female Rats Exposed to Cisplatin
- PMID: 40626517
- PMCID: PMC12236056
- DOI: 10.1002/cbf.70101
Persistent Renal Oxidative Stress Despite Mannitol Nephroprotection: The Impact of Social-Single Prolonged Stress in Male and Female Rats Exposed to Cisplatin
Abstract
Cisplatin (CIS) is a chemotherapeutic agent known for nephrotoxicity through oxidative stress. Cancer treatment is also associated with psychological stress. Repeated exposure to social-single prolonged stress (social-SPS) modulates long-term renal oxidative damage and apoptosis in a sex-dependent manner in rats treated with cisplatin (CIS), despite mannitol's nephroprotective effects. We investigated whether repeated exposure to social-single prolonged stress (social-SPS) modulates long-term renal oxidative damage and apoptosis in male and female rats treated with CIS and mannitol. Male and female Wistar rats were divided into three groups: control, CIS + mannitol, and CIS + mannitol + social-SPS. Mannitol was administered 1 h before CIS (2 mg/kg/day, i.p., for 5 days). Social-SPS was applied at three time points. At postnatal day 68, blood and kidney samples were collected for biochemical and Western blot analyses. Plasma renal biomarkers remained unchanged across groups. However, social-SPS increased renal lipid peroxidation (TBARS) and protein oxidation (carbonyl content) in both sexes. CIS+social-SPS decreased catalase activity and altered SOD, GST, and NPSH in a sex-dependent manner. Only female rats showed increased renal BAX/Bcl2 ratio, indicating apoptosis. In males, Na⁺/K⁺-K-ATPase activity correlated positively with NPSH content. Despite mannitol nephroprotection, social stress exacerbated renal oxidative stress. Female rats were more susceptible to apoptosis, suggesting sex-specific vulnerability to combined CIS and stress exposure. These findings highlight the importance of considering psychological stress and sex as modulators of chemotherapeutic toxicity and may inform future strategies for personalized cancer care.
Keywords: apostosis; chemotherapy; cisplatin; sex‐differences; stress.
© 2025 The Author(s). Cell Biochemistry and Function published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interests.
Figures





Similar articles
-
Evaluation of the impact of Momordica Charantia on the testis of cisplatin-treated albino rats: Biochemical, histopathological, and ultrastructural study.Histol Histopathol. 2025 Aug;40(8):1209-1226. doi: 10.14670/HH-18-867. Epub 2024 Dec 30. Histol Histopathol. 2025. PMID: 39803815
-
Cardiovascular and neuroimmune adaptations to enalapril and exercise training: A comparative study in male and ovariectomized female spontaneously hypertensive rats.Auton Neurosci. 2025 Aug;260:103280. doi: 10.1016/j.autneu.2025.103280. Epub 2025 Apr 12. Auton Neurosci. 2025. PMID: 40253895
-
Synergistic protective activity of sodium hydrosulfide and L-arginine against cisplatin-induced nephrotoxicity, even during nitric oxide synthase inhibition.J Pharmacol Exp Ther. 2025 Jul;392(7):103618. doi: 10.1016/j.jpet.2025.103618. Epub 2025 May 27. J Pharmacol Exp Ther. 2025. PMID: 40602357
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
References
-
- Shabani M., Larizadeh M. H., Parsania S., Hajali V., and Shojaei A., “Evaluation of Destructive Effects of Exposure to Cisplatin During Developmental Stage: No Profound Evidence for Sex Differences in Impaired Motor and Memory Performance,” International Journal of Neuroscience 122, no. 8 (2012): 439–448, 10.3109/00207454.2012.673515. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials